Sera Prognostics (SERA) Short term Debt (2020)
Sera Prognostics (SERA) posted Short term Debt of $4.4 million for Q4 2020.
Sera Prognostics (SERA) Short term Debt (2020) Analysis & Trends
Sera Prognostics' Short term Debt history runs 1 years deep, the most recent figure standing at $4.4 million for Q4 2020.
- Quarterly Short term Debt changed N/A year-over-year to $4.4 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $4.4 million (changed N/A YoY) and the FY2020 annual result came in at $4.4 million, changed N/A from the prior year.
- Short term Debt was $4.4 million for Q4 2020 at Sera Prognostics.
- Across five years, Short term Debt topped out at $4.4 million in Q4 2020 and bottomed at $4.4 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn |
| 10 | Sera Prognostics | 107.05 Mn | 107.05 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 4.35 Mn |